In response to the Letter to the Editor by Romach et al. re our publication "Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels".
EBioMedicine
; 66: 103334, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33862586
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Fetus
/
Heterocyclic Compounds, 3-Ring
Type of study:
Risk_factors_studies
Limits:
Animals
/
Pregnancy
Language:
En
Journal:
EBioMedicine
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: